Pharmaceutical Firm Licenses Promising Poison Ivy Preventative
Monday, March 26, 2012 - 08:01
in Health & Medicine
Hapten Sciences Inc. has licensed a compound developed by university researchers that shows promise in preventing reactions to poison ivy, oak and sumac. The potential drug could end the misery of itching and blistering for millions of Americans each summer.